Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

OVA66, a tumor associated protein, induces oncogenic transformation of NIH3T3 cells.

Rao W, Xie G, Zhang Y, Wang S, Wang Y, Zhang H, Song F, Zhang R, Yin Q, Shen L, Ge H.

PLoS One. 2014 Mar 14;9(3):e85705. doi: 10.1371/journal.pone.0085705. eCollection 2014.

2.

OVA66 increases cell growth, invasion and survival via regulation of IGF-1R-MAPK signaling in human cancer cells.

Rao W, Li H, Song F, Zhang R, Yin Q, Wang Y, Xi Y, Ge H.

Carcinogenesis. 2014 Jul;35(7):1573-81. doi: 10.1093/carcin/bgu070. Epub 2014 Mar 25.

PMID:
24667688
4.
5.

Endocrine resistance associated with activated ErbB system in breast cancer cells is reversed by inhibiting MAPK or PI3K/Akt signaling pathways.

Ghayad SE, Vendrell JA, Ben Larbi S, Dumontet C, Bieche I, Cohen PA.

Int J Cancer. 2010 Jan 15;126(2):545-62. doi: 10.1002/ijc.24750.

6.

Oncostatin M induction of eotaxin-1 expression requires the convergence of PI3'K and ERK1/2 MAPK signal transduction pathways.

Smyth DC, Kerr C, Li Y, Tang D, Richards CD.

Cell Signal. 2008 Jun;20(6):1142-50. doi: 10.1016/j.cellsig.2008.02.001. Epub 2008 Feb 11.

PMID:
18372159
7.
8.

Epidermal growth factor induces HCCR expression via PI3K/Akt/mTOR signaling in PANC-1 pancreatic cancer cells.

Xu Z, Zhang Y, Jiang J, Yang Y, Shi R, Hao B, Zhang Z, Huang Z, Kim JW, Zhang G.

BMC Cancer. 2010 Apr 27;10:161. doi: 10.1186/1471-2407-10-161.

9.

The chimeric protein tyrosine kinase ETV6-NTRK3 requires both Ras-Erk1/2 and PI3-kinase-Akt signaling for fibroblast transformation.

Tognon C, Garnett M, Kenward E, Kay R, Morrison K, Sorensen PH.

Cancer Res. 2001 Dec 15;61(24):8909-16.

10.

[Combined inhibition of PI3K and MEK has synergistic inhibitory effect on the proliferation of cisplatin-resistant ovarian cancer cells].

Liu Y, Chen X, Luo Z.

Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2014 Jun;30(6):592-6. Chinese.

PMID:
24909280
11.
13.

Cardioprotection induced by hydrogen sulfide preconditioning involves activation of ERK and PI3K/Akt pathways.

Hu Y, Chen X, Pan TT, Neo KL, Lee SW, Khin ES, Moore PK, Bian JS.

Pflugers Arch. 2008 Jan;455(4):607-16. Epub 2007 Aug 1.

PMID:
17674030
14.

[Molecular mechanism of chemosensitization to paclitaxel in human melanoma cells induced by targeting the EGFR signaling pathway].

Zhang XJ, Zhang L, Liu YP, Xu HM, Sun P, Song JG, Luo YH.

Zhonghua Zhong Liu Za Zhi. 2013 Mar;35(3):181-6. doi: 10.3760/cma.j.issn.0253-3766.2013.03.005. Chinese.

PMID:
23879997
15.

[Salidroside via ERK1/2 and PI3K/AKT/mTOR signal pathway induces mouse bone marrow mesenchymal stem cells differentiation into neural cells].

Chen YN, Liu H, Zhao HB, Liu Y, Bai J, Zhu XJ, Wang Y.

Yao Xue Xue Bao. 2013 Aug;48(8):1247-52. Chinese.

PMID:
24187831
16.

Insulin-like growth factor I-mediated protection from rapamycin-induced apoptosis is independent of Ras-Erk1-Erk2 and phosphatidylinositol 3'-kinase-Akt signaling pathways.

Thimmaiah KN, Easton J, Huang S, Veverka KA, Germain GS, Harwood FC, Houghton PJ.

Cancer Res. 2003 Jan 15;63(2):364-74.

17.

Anti-apoptotic signaling by hepatocyte growth factor/Met via the phosphatidylinositol 3-kinase/Akt and mitogen-activated protein kinase pathways.

Xiao GH, Jeffers M, Bellacosa A, Mitsuuchi Y, Vande Woude GF, Testa JR.

Proc Natl Acad Sci U S A. 2001 Jan 2;98(1):247-52.

18.

[Effects of PD98059 and LY294002 on subcutaneous xenograft of human endometrial carcinoma in nude mice].

Guo RX, Zhang RF, Wang XY, Shi HR, Qiao YH.

Zhonghua Fu Chan Ke Za Zhi. 2011 Jun;46(6):446-52. Chinese.

PMID:
21781587
19.

Apelin-13 protects the brain against ischemia/reperfusion injury through activating PI3K/Akt and ERK1/2 signaling pathways.

Yang Y, Zhang X, Cui H, Zhang C, Zhu C, Li L.

Neurosci Lett. 2014 May 7;568:44-9. doi: 10.1016/j.neulet.2014.03.037. Epub 2014 Mar 29.

PMID:
24686182
20.

Rit, a non-lipid-modified Ras-related protein, transforms NIH3T3 cells without activating the ERK, JNK, p38 MAPK or PI3K/Akt pathways.

Rusyn EV, Reynolds ER, Shao H, Grana TM, Chan TO, Andres DA, Cox AD.

Oncogene. 2000 Sep 28;19(41):4685-94.

Supplemental Content

Support Center